Active ingredients: Cefuroxime
Zinnat 125 mg film-coated tablets.
Film-coated tablet (tablet).
Each tablet contains 125 mg cefuroxime (as cefuroxime axetil).
Excipient(s) with known effect:
Each tablet contains 0.00152 mg sodium benzoate (E211)
Each tablet contains Methyl parahydroxybenzoate (E218) and Propyl parahydroxybenzoate (E216)
For the full list of excipients, see section 6.1.
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
Hydrogenated vegetable oil
Silica Colloidal Anhydrous
Methyl parahydroxybenzoate (E218)
Propyl parahydroxybenzoate (E216)
Opaspray white M-1-7120J [containing titanium dioxide (E171) and sodium benzoate (E211)]
Aluminium foil blister pack with an aluminium lid.
Pack size: 6, 10, 12, 14, 16, 20, 24 and 50
Not all pack sizes may be marketed.
Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
15 October 1998